Infection Prevention and Control

Stay informed on the latest news and developments in infection prevention and control. AHA provides valuable resources and support to help you maintain a safe and clean environment.

The Biden Administration released a strategy to better prepare and protect the nation from future pandemics and biological threats, and called for Congress to provide $88 billion over five years to help implement the plan. 
During the COVID-19 public health emergency, CMS will continue to exercise enforcement discretion under the Clinical Laboratory Improvement Amendments to allow providers to test asymptomatic individuals using certain point-of-care SARS-CoV-2 tests authorized for symptomatic individuals, CMS…
Monkeypox cases have dropped nearly 50% since early August, the White House said today, affirming the effectiveness of a national mitigation strategy where vaccination and education are used in tandem.
HHS purchased $26 million worth of intravenous TPOXX (tecovirimat) to treat monkeypox, which the manufacturer expects to deliver next year.
President Biden named Federal Emergency Management Agency Region 9 Administrator Robert Fenton to coordinate the administration’s monkeypox response.
Inpatient and outpatient prospective payment system hospitals, inpatient psychiatric facilities and PPS-exempt cancer hospitals have until Aug. 30 to preview their data for the October update to Care Compare.
World Health Organization Director-General Tedros Adhanom Ghebreyesus Saturday declared monkeypox a public health emergency of international concern and recommended governments take certain steps to strengthen and coordinate the global response to the outbreak.
The CDC endorsed the two-dose Novavax COVID-19 vaccine as a COVID-19 vaccine primary series for emergency use in adults, as recommended by its advisory committee.
The CDC's Advisory Committee on Immunization Practices today recommended the two-dose Novavax COVID-19 vaccine as a COVID-19 vaccine primary series for emergency use in adults.
A third and fourth dose of the Pfizer or Moderna COVID-19 vaccine provided additional protection to eligible adults, the CDC reported Friday.